VAERS reports by lot

Pfizer Pneumococcal lot GN1897: VAERS reports

37 VAERS reports list lot GN1897 as a Pfizer Pneumococcal vaccine, received between 2023-04-15 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
37
Reports
5%
Marked serious
1
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5635%
General / Systemic (non-local)2516%
Allergic / Anaphylactic159%
Dermatological (non-injection-site)159%
Neurological128%
Gastrointestinal117%
Musculoskeletal106%
Cardiac / Cardiovascular74%
Respiratory64%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York6
California6
Texas3
North Carolina3
Florida2
Pennsylvania2
Minnesota2
New Mexico2
Connecticut1
Nevada1
Michigan1
Ohio1

Reports by month received

2023-043
2023-0510
2023-0610
2023-072
2023-082
2023-092
2023-102
2023-121
2024-041
2024-052
2024-062

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.